U.S. markets closed

Is it Time to Buy Cannabis Stocks & ETFs?

Neena Mishra
  • (1:00) - Stock Valuations: Is The Stock Market Getting Ahead of Itself?
  • (8:20) - Cannabis Industry Rebounds After The 2019 Downfall
  • (14:10) - What Impact Did The Industry See From Covid-19?
  • (17:00) - What Are The Growth Expectations For The Cannabis Industry?
  • (25:45) - What Are The Legal Challenges The Industry Faces?
  • (29:00) - Amplify Seymour Cannabis ETF: CNBS
  • (42:30) - Amplify Online Retail ETF: IBUY
  •     Podcast@Zacks.com

 

In this episode of ETF Spotlight, I speak with Tim Seymour, CIO of Seymour Asset Management and co-host of CNBC's Fast Money, and Christian Magoon, CEO of Amplify ETFs. We discuss cannabis investing and the Amplify Seymour Cannabis ETF CNBS, which is actively managed by Tim.

Major indexes have rebounded strongly from their March lows as investors have started looking past the grim economic data and the health crisis. Is there a disconnect between the economy and stock market?

2019 was terrible for most pot stocks and the underperformance continued earlier this year, but many of them rebounded in late March. Is the worst over for pot stocks?

Cannabis shops were deemed essential services in many states and remained open during coronavirus related lockdowns. After some panic buying initially, sales have seen steady growth as consumption continues to rise.

Medical marijuana is legal in 33 states and in the District of Columbia, while recreational use is legal in 11 states and in the District of Columbia, but it remains illegal on the federal level. Should we expect any major changes in the regulatory landscape for marijuana?

GW Pharmaceuticals GWPH, Canopy Growth Corporation CGC. Cronos Group CRON and Innovative Industrial Properties IIPR are CNBS’s top holdings. IIPR, a cannabis-focused REIT, has done quite well this year. What do investors need to know about these companies?

We also talk about the Amplify Online Retail ETF IBUY which is one of the top performing ETFs this year. And we may see a permanent shift in consumer behavior toward online shopping even after the health crisis is over.

Make sure to be on the lookout for the next edition of ETF Spotlight! If you have any comments or questions, please email podcast@zacks.com.

(In full disclosure, Neena owns shares of IBUY in the ETF Investor Portfolio.)

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
GW Pharmaceuticals PLC (GWPH) : Free Stock Analysis Report
 
Amplify Online Retail ETF (IBUY): ETF Research Reports
 
Innovative Industrial Properties, Inc. (IIPR) : Free Stock Analysis Report
 
Canopy Growth Corporation (CGC) : Free Stock Analysis Report
 
Cronos Group Inc. (CRON) : Free Stock Analysis Report
 
Amplify Seymour Cannabis ETF (CNBS): ETF Research Reports
 
To read this article on Zacks.com click here.
 
Zacks Investment Research